CAR T Cells in Mesothelin-Expressing Breast Cancer
NCT05623488
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
2
Enrollment
OTHER
Sponsor class
Stopped
Feasibility Concerns
Conditions
Breast Cancer
Interventions
DRUG:
huCART-meso cells
DEVICE:
Mesothelin Expression Testing
Sponsor
University of Pennsylvania